For the Many
The pharmaceutical industry must be encouraged to look beyond patients in advanced economies to all patients who could benefit from innovative medicines, no matter where they live
Charles Gore | | Opinion
Trying to fathom the frustration felt by a mother who is unable to afford her child’s life-saving drugs is difficult in the extreme. But during my time with the World Hepatitis Alliance (before I joined the Medicines Patent Pool), I was faced with just that situation. I met a mother who had sold everything she owned to help purchase medicines for her son, but she still had a long way to go to give her child the drugs he so desperately needed.
And it’s far from an isolated case. Over 2 billion people worldwide don’t have sufficient access to essential medicines and health products. Those of us who have been involved in patient advocacy anywhere will not be unfamiliar with the feelings of frustration and failure in not being able to help such patients in meaningful ways. So how do we move forward?
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine